← SynDRA
Oicr-9429
SynDRA canonical compound SYN0061239 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | WDR5 |
|---|
| Mechanism of action | WDR5/MLL interaction inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- WDR5 BINDER
- WDR5/MLL interaction inhibitor
- WDR5 ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- AKOS025147341
- GTPL8231
- OICR 9429
- OICR9429
- CHEMBL3798846
- N-(4-(4-Methylpiperazin-1-Yl)-3'-(Morpholinomethyl)-[1,1'-Biphenyl]-3-Yl)-6-Oxo-4-(Trifluoromethyl)-1,6-Dihydropyridine-3-Carboxamide
- N-[2-(4-methylpiperazin-1-yl)-5-[3-(morpholin-4-ylmethyl)phenyl]phenyl]-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide
- MolPort-039-101-294
- EX-A2417
- BCP18185
- BDBM50164794
- s7833
- ZINC231558892
- SB19642
- CS-5776
- NCGC00371263-02
- AK468854
- HY-16993
- J3.618.049H
- RefChem:168004
- MFCD28411621
- orb1300349
- SCHEMBL20896072
- SCHEMBL29596126
- OICR9429?
- C29H32F3N5O3
- DJOVLOYCGXNVPI-UHFFFAOYSA-N
- GLXC-06265
- NSC786093
- NSC788992
- CCG-270032
- EBC-515477
- NSC-786093
- NSC-788992
- NCGC00371263-06
- AC-36065
- AS-75212
- BO163662
Look up Oicr-9429 in the interactive SynDRA portal →